-transparent.png){kind=logo}
The mechanisms by which insulin inhibits catecholamine-induced lipolysis in fat cells are unknown. In this study the possible role of an interaction between insulin and the adrenoceptors on human fat cells was investigated. Insulin inhibited, in a dose-dependent fashion, the specific binding of hydrophobic as well as hydrophilic nonselective beta-receptor radioligands but had no effect on the binding of alpha 2-selective radioligands. The results of saturation experiments and competition-inhibition experiments under both equilibrium conditions and nonequilibrium conditions revealed that insulin reduced the total number of beta-adrenergic binding sites (maximum effect 25%) without changing the beta-adrenoceptor affinity. This insulin effect was rapid and reversible; one-third of the effect occurred within 1 min of incubation and it was completely reversed within 30 min after withdrawal of insulin. It could be mimicked by a polyclonal rabbit insulin receptor antibody but not by insulin mimickers acting distal to the initial interaction between the hormone and its specific insulin-receptor binding site. The beta-adrenoceptor binding to a plasma membrane-enriched fraction decreased at the same time as it increased to a microsomal enriched fraction after insulin treatment, indicating a redistribution of beta-adrenoceptors in the cell. In lipolysis experiments performed under conditions like those in the binding experiments, insulin inhibited the rate of lipolysis with a lag period of 3 min. Furthermore, the hormone caused a dose-dependent maximum 10-fold shift to the right of the dose-response curve for isoprenaline-induced lipolysis without changing the amplitude of the curve. This effect of insulin was specific for the beta-adrenergic receptors system, since insulin markedly decreased the amplitude of the dose-response curve for parathyroid hormone-induced lipolysis. In addition, the effect of insulin on isoprenaline-induced lipolysis could be mimicked by long-lasting fractional inactivation of the beta-adrenoceptors. The dose-response relationships for the inhibitory effects of insulin on beta-adrenoceptor binding and the lipolytic sensitivity to isoprenaline were almost identical. Half-maximum and maximum effects occurred at about 5 and 100 microunits/ml of insulin, respectively. In conclusion, the exposure of human fat cells to physiological insulin doses is followed by a rapid and dose-dependent translocation of beta-adrenoceptors from the exterior to the interior of the cell and a subsequent dose-dependent decrease in the lipolytic sensitivity to beta-adrenergic agonists, without a change in maximum lipolysis.(ABSTRACT TRUNCATED AT 400 WORDS)
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
June 1987,
The Journal of clinical investigation,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
January 1974,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
March 1989,
Biochemical pharmacology,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
June 1979,
Biochimica et biophysica acta,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
January 1992,
Journal of nutritional science and vitaminology,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
March 1971,
The Biochemical journal,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
December 1974,
Biochimica et biophysica acta,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
January 1972,
Acta diabetologica latina,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
July 1967,
Endocrinology,
P Engfeldt, and
J Hellmér, and
H Wahrenberg, and
P Arner
September 1995,
Obesity research,
